Literature DB >> 25924240

Authors' reply.

N Dominguez-Pinilla, M Baro-Fernández, L I Gonzalez-Granado.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25924240      PMCID: PMC4943434     

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


× No keyword cloud information.
Sir, We thank Chhabra P for their comments.[1] The HIV test in our patient returned negative (HIV tests during pregnancy were also negative). It has also been reported HLH in AIDS is secondary not to the virus itself, but to overwhelming infections (particularly Pneumocystis jiroveci and nontuberculous mycobacteria). Complex immune mechanisms in HIV-Leishmania have been reported elsewhere.[2] In our country comparison between different microbiological techniques has been reported. However, serology is neither sensitive nor specific in the general Spanish population[3] and in HIV patients.[4] Our data on file in a pediatric cohort of HLH-Leishmania patients shows that only 32% of patients had a positive urine test. Thus, in our country the most reliable test remains PCR in bone marrow samples, followed by PCR in peripheral blood.
  4 in total

1.  Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.

Authors:  José A García-García; Joaquina Martín-Sánchez; Montserrat Gállego; Antonio Rivero-Román; Angela Camacho; Cristina Riera; Francisco Morillas-Márquez; Salvador Vergara; Juan Macías; Juan A Pineda
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

2.  Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis.

Authors:  Israel Cruz; Carmen Chicharro; Javier Nieto; Begoña Bailo; Carmen Cañavate; María-Concepción Figueras; Jorge Alvar
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 3.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

4.  Offender: virus or parasite or both.

Authors:  P Chhabra
Journal:  J Postgrad Med       Date:  2015 Apr-Jun       Impact factor: 1.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.